The use of GLP-1s among patients with type 2 diabetes appeared associated with significantly reduced risk for certain ...

Long-term results from a randomized trial confirmed that early rituximab monotherapy for advanced-stage, asymptomatic, low ...

IGI reported that it has recently wrapped up the dose-escalation phase of its Phase 1 clinical trial involving patients with ...

The final ALCYONE analysis with 86.7-month follow-up shows daratumumab-VMP significantly improved overall survival in ...

Following promising phase 1 data, ISB 2001 has gained fast track designation from the FDA for the treatment of ...

The new test focuses on mutations in the NPM1 and FLT3 genes, which are among the most common causes of leukemia in younger ...

A revolutionary bone marrow test helped save a woman’s life by detecting her leukemia relapse months before standard methods.

Initial study results for ISB 2001, which treats relapsed or refractory multiple myeloma, demonstrated a high overall ...

Exome sequencing (ES) is commonly used to diagnose Mendelian disorders, which occur when pathogenic variant(s) in a gene are ...

An investigational viral immunotherapy extended survival compared with standard care for patients with advanced non-small cell lung cancer who had inadequate response to immune checkpoint inhibitor ...

"A drug receiving fast track tag also may be eligible for priority review if relevant criteria are met. ISB 2001 was ...

Beam Therapeutics and Verve Therapeutics have each built their lead candidates on a technique billed as a safer alternative ...